Ketamine for Treatment-Resistant Unipolar Depression

CNS Drugs - United Kingdom
doi 10.2165/11599770-000000000-00000
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Lithium for Long-Term Treatment of Unipolar Depression

The Lancet Psychiatry
PsychiatryBiological PsychiatryMental Health
2017English

S-(+)-Ketamine-Induced Dissociative Symptoms as a Traumatic Experience in Patients With Treatment-Resistant Depression

Revista Brasileira de Psiquiatria
PsychiatryMental Health
2017English

Add-On Lithium for the Treatment of Unipolar Depression: Too Often Forgotten?

Journal of Psychiatry and Neuroscience
MedicinePsychiatryBiological PsychiatryMental HealthPharmacology
2015English

Approval of Esketamine for Treatment-Resistant Depression

The Lancet Psychiatry
PsychiatryBiological PsychiatryMental Health
2020English

Ketamine and Depression

British Journal of Anaesthesia
AnesthesiologyPain Medicine
2018English

Treatment Resistant Depression in Women With Peripartum Depression

BMC Pregnancy and Childbirth
GynecologyObstetrics
2019English

Neurophysiological Effect of Ketamine on Prefrontal Cortex in Treatment-Resistant Depression: A Combined Transcranial Magnetic Stimulation–Electroencephalography Study

Chronic Stress
2019English

Treatment-Resistant and Multi-Therapy-Resistant Criteria for Bipolar Depression: Consensus Definition

British Journal of Psychiatry
MedicinePsychiatryMental Health
2018English

Treatment-Resistant Depression in Later Life

Journal of Psychiatry and Neuroscience
MedicinePsychiatryBiological PsychiatryMental HealthPharmacology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy